The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Bilal Siddiqui Honoraria - Cancer Expert Now; Cardinal Health; Curio Science; DAVA Pharmaceuticals Consulting or Advisory Role - Amgen; Bayer; Johnson and Johnson; Merck; Pfizer; Survivornet Research Funding - Amgen (Inst); Cancer Research Institute; Conquer Cancer, the ASCO Foundation; Johnson & Johnson/Janssen (Inst); Prostate Cancer Foundation; Regeneron (Inst) Travel, Accommodations, Expenses - Cardinal Health; Curio Science; Merck   Mark Stein Stock and Other Ownership Interests - Rafael Holdings Consulting or Advisory Role - Exelixis; GI Innovation; Johnson & Johnson/Janssen Research Funding - ARTBIO (Inst); AstraZeneca (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); DualityBio (Inst); Exelixis (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Regeneron (Inst); Telix Pharmaceuticals (Inst); Xencor (Inst)   Jingsong Zhang Consulting or Advisory Role - Dendreon; JNJ; Sanofi; Tolmar   Gerald Falchook Employment - HealthONE; Sarah Cannon Research Institute Honoraria - Clinical Care Options Consulting or Advisory Role - Abbvie (Inst); BostonGene (Inst); BostonGene (Inst); BridgeBio Pharma (Inst); EMD Serono; Fujifilm (Inst); Inspirna (Inst); Jubilant Pharmaceuticals (Inst); Merck (Inst); Navire (Inst); Predicine (Inst); Regeneron (Inst); Sanofi (Inst); Silicon Therapeutics (Inst); Silicon Therapeutics (Inst); Teon Therapeutics (Inst); Turning Point Therapeutics (Inst) Speakers' Bureau - Total Health Conferencing Research Funding - 3-V Biosciences (Inst); Abbisko (Inst); Abbvie (Inst); ABL Bio (Inst); Accutar Biotech (Inst); ADC Therapeutics (Inst); Agenus (Inst); Aileron Therapeutics (Inst); American Society of Clinical Oncology (Inst); Amgen (Inst); ARMO BioSciences (Inst); Artios (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bicycle Therapeutics (Inst); Bioatla (Inst); BioInvent (Inst); Biomea Fusion (Inst); Biothera (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Celldex (Inst); Centessa Pharmaceuticals (Inst); Ciclomed (Inst); Conjupro Biotherapeutics (Inst); Curegenix (Inst); Curis (Inst); Cyteir (Inst); Daiichi (Inst); DelMar Pharmaceuticals (Inst); eFFECTOR Therapeutics (Inst); Eikon Therapeutics (Inst); EMD Serono (Inst); Epizyme (Inst); Erasca, Inc (Inst); Exelixis (Inst); Freenome (Inst); Fujifilm (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Harbour BioMed (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); IgM Biosciences (Inst); Ignyta (Inst); Immunitas (Inst); Immunogen/MacroGenics (Inst); Incyte (Inst); Jacobio (Inst); Jazz Pharmaceuticals (Inst); Jounce Therapeutics (Inst); Jubilant Pharmaceuticals (Inst); Kineta (Inst); Kolltan Pharmaceuticals (Inst); Kura Oncology (Inst); Lilly (Inst); Loxo (Inst); MD Anderson Cancer Center (Inst); MedImmune (Inst); Merck (Inst); Metabomed (Inst); Millennium (Inst); Mirati Therapeutics (Inst); miRNA Therapeutics (Inst); Molecular Templates (Inst); National Institute of Health (NIH) (Inst); Navire (Inst); NGM Biopharmaceuticals (Inst); NiKang Therapeutics (Inst); Novartis (Inst); Nuvectis Pharma (Inst); OncoMed (Inst); Oncorus (Inst); Oncothyreon (Inst); Phanes Therapeutics (Inst); Poseida (Inst); Precision Oncology (Inst); Prelude Therapeutics (Inst); PureTech (Inst); Pyramid Biosciences (Inst); Pyxis (Inst); RasCal (Inst); Regeneron (Inst); Relay Therapeutics (Inst); Rgenix (Inst); Ribon Therapeutics (Inst); Roche (Inst); Samumed (Inst); Sapience Therapeutics (Inst); Sarah Cannon Research Institute (Inst); Seagen (Inst); Silicon Therapeutics (Inst); Simcha Therapeutics (Inst); Sirnaomics (Inst); Strategia Therapeutics (Inst); Syndax (Inst); Synthorx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tallac Therapeutics (Inst); Tango Therapeutics (Inst); Tarus Therapeutics (Inst); Tarveda Therapeutics (Inst); TeneoBio (Inst); Tesaro (Inst); Tocagen (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst); Xencor (Inst); Zhuhai Yufan Biotechnologies (Inst) Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; EMD Serono; Fujifilm; Millennium; Sarah Cannon Research Institute; Synthorx/Sanofi   Przemyslaw Twardowski Consulting or Advisory Role - AstraZeneca Speakers' Bureau - Astellas Pharma; AstraZeneca; Aveo; Bayer; Bristol-Myers Squibb; Janssen; Merck; Pfizer; Seagen; Tolma   Xin Gao Consulting or Advisory Role - 858 Therapeutics; Abeona Therapeutics; ADC Therapeutics; Arvinas; Bayer; Flare Therapeutics; Hinova Pharmaceuticals; Janssen; Kanaph Therapeutics; Loxo/Lilly Research Funding - ALX Oncology (Inst); Aprea Therapeutics (Inst); Aravive (Inst); Arvinas (Inst); Bayer (Inst); Exelixis (Inst); Halda Therapeutics (Inst); Harpoon therapeutics (Inst); Janux Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Pfizer (Inst); Poseida therapeutics (Inst); Regeneron (Inst); Takeda (Inst); TopAlliance BioSciences Inc (Inst)   Joseph Kim Consulting or Advisory Role - Halda Therapeutics; Janssen Biotech Research Funding - Abbvie (Inst); Acrivon Therapeutics (Inst); ADC Therapeutics (Inst); Antengene (Inst); AstraZeneca (Inst); Cosmo Pharmaceuticals; Dendreon (Inst); Exelixis (Inst); Halda Therapeutics (Inst); Hummingbird (Inst); IgM Biosciences (Inst); Janux Therapeutics (Inst); Regeneron (Inst); Roche (Inst)   Edward Gelmann Stock and Other Ownership Interests - Bristol-Myers Squibb (I); Johnson & Johnson (I); Lilly (I); Vertex Research Funding - Hibercell (Inst); Regeneron (Inst)   Benedito Carneiro Consulting or Advisory Role - Abbvie; ADC Therapeutics; Eisai Research Funding - Abbvie (Inst); Actuate Therapeutics (Inst); Agenus (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Dragonfly Therapeutics (Inst); MiNK Therapeutics (Inst); Pfizer (Inst); Pyxis (Inst); Regeneron (Inst); Repare Therapeutics (Inst)   David Wise Stock and Other Ownership Interests - Doximity Honoraria - OncLive; ScientiaCME Consulting or Advisory Role - Bayer; Janssen; K36; OncoC4; Pfizer Travel, Accommodations, Expenses - Bayer; Bayer; Pfizer   Benjamin Gartrell Honoraria - Janssen Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Blue Earth Diagnostics; Eisai; Janssen; Novartis; Pfizer Speakers' Bureau - Bristol Myers Squibb Foundation Research Funding - Pfizer (Inst)   I. Alex Bowman Consulting or Advisory Role - AVEO; Exelixis; Pfizer Speakers' Bureau - Caris Life Sciences   Robert Dreicer Consulting or Advisory Role - Astellas Pharma; LNC Pharma; Merck; Pfizer; Urogen pharma Research Funding - Exelixis (Inst)   Shilpa Govindraj Employment - Regeneron Pharmaceuticals Ltd Stock and Other Ownership Interests - Regeneron Pharmaceuticals Ltd   Pradeep Thanigaimani Employment - Regeneron Stock and Other Ownership Interests - Regeneron   Fang Fang Employment - Regeneron Stock and Other Ownership Interests - Regeneron   Frank Seebach Employment - Regeneron Leadership - Regeneron Stock and Other Ownership Interests - Regeneron   Michael Kinnaman Employment - Regeneron Stock and Other Ownership Interests - Regeneron   Sabina Sandigursky Employment - Regeneron Stock and Other Ownership Interests - Regeneron   Elizabeth Miller Employment - Regeneron Stock and Other Ownership Interests - Regeneron Patents, Royalties, Other Intellectual Property - involved in patents through employment at Regeneron Travel, Accommodations, Expenses - Regeneron